NCT07292922

Brief Summary

This pilot study explores the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative program combining facial recognition technology with evidence-based orofacial exercises for individuals with mild to moderate obstructive sleep apnoea (OSA). The d-MFT program aims to strengthen oropharyngeal muscles, improve airway function, and reduce OSA severity. Participants receiving 3-month d-MFT (n=30) are expected to demonstrate greater improvements in OSA severity, sleep-related symptoms, and quality of life compared to those in the waitlist control group (n=30). Feasibility and acceptability will be evaluated through outcome-based questionnaires and semi-structured interviews to explore participants' experiences, satisfaction, and perceived barriers to adherence.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
12mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Jan 2026Apr 2027

First Submitted

Initial submission to the registry

December 6, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 18, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

January 5, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.1 years

First QC Date

December 6, 2025

Last Update Submit

March 11, 2026

Conditions

Keywords

Orofacial Myofunctional Therapy

Outcome Measures

Primary Outcomes (2)

  • Programme satisfaction

    measured by outcome-based questions with a 5-point Likert scale (ranging from 1 to 5 points). Higher scores indicate higher satisfaction.

    month 3

  • Change in oxygen saturation

    Measured by sleep test

    Baseline and month 3

Secondary Outcomes (5)

  • Change in respiratory Indices

    Baseline, month 3

  • Change in snoring

    Baseline, month 3

  • Change in sleep quality

    Baseline, month 3

  • Change in daily function

    Baseline, month 3

  • Change in oropharyngeal muscle function

    Baseline, month 3

Study Arms (2)

Waitlist Control Group

NO INTERVENTION

The waitlist control group will not receive any intervention within the study period

d-MFT Intervention Group

EXPERIMENTAL

The d-MFT intervention group will participate in a 3-month digital-support Myofunctional Therapy program. This innovative program is designed to ensure proper exercise performance, enhance adherence, and provide real-time feedback to patients.

Behavioral: Digital-supported Orofacial Myofunctional Therapy

Interventions

The intervention include: (1) Five 30-minute d-MFT sessions; (2) two follow-up phone calls; and (3) facial and tongue exercise app for home practice.

d-MFT Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years and above
  • Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as: Apnoea-Hypopnea Index of 5-30 events per hour
  • Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments
  • Body Mass Index less than 30 kg/m2

You may not qualify if:

  • Presence of obstructive nasal disease or significant nasal obstruction
  • Unstable mental health issues
  • History of stroke
  • Unstable chronic respiratory, cardiac, neurological conditions
  • Inability to provide informed consent
  • Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Mary Hopsital

Hong Kong, Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Agnes YK Lai, PhD

    Hong Kong Metropolitan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agnes YK Lai, PhD

CONTACT

George OC Cheung, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 6, 2025

First Posted

December 18, 2025

Study Start

January 5, 2026

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

April 30, 2027

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

It has not been mentioned during the IRB application.

Locations